Quantcast

Latest Clinical pharmacology Stories

2014-10-30 16:29:12

-- Optimizes resources by leveraging shared-services -- HAYWARD, Calif., Oct. 30, 2014 /PRNewswire/ -- Impax Laboratories, Inc. (NASDAQ: IPXL) today announced a reorganization of its research and development (R&D) organizations and a prioritization of the project portfolios within the generic and brand businesses. As a result of the reorganization, the generic R&D organization will be responsible for early stage product development and analytical functions for all Impax products,...

2014-10-28 23:13:08

Is the de novo process right for a particular medical device? To help manufacturers decide, FDAnews is pleased to present a 90-minute webinar on Nov. 20 that will explain the new one-step de novo procedure and tell manufacturers what they must do to ensure that the petition includes all the data elements and supporting research the FDA requires. Falls Church, VA (PRWEB) October 28, 2014 Device De Novo Reclassification: FDA’s New Direct De Novo Petitions in Action **FDAnews Webinar**...

2014-10-27 23:10:32

The FDA's enforcement plan makes it clear: Developing a successful CAPA program has never been more important. FDAnews and Compliance Media, Inc. are offering an advanced version of their previous CAPA investigations class, fully updated to meet tough FDA scrutiny in 2014. Falls Church, VA (PRWEB) October 27, 2014 Conducting Advanced Root Cause Analysis and CAPA Investigations Understanding Advanced Critical Thinking Skills and Innovative Techniques to Improve the Quality of...

2014-10-23 08:35:58

UNION CITY, Calif., Oct. 23, 2014 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care instruments and consumables for the medical, research, and veterinary markets worldwide and providing reference lab services to the veterinary and research markets in the United States, announced today it has appointed Ross Taylor as Vice President of Business Development and Investor Relations, effective immediately. Mr. Taylor will be responsible...

2014-10-22 23:11:09

The appropriate handling of inspections can affect the timing of approvals and may mean the difference in whether the agency takes a regulatory action or grants a product approval. FDAnews has invited John Avellanet, an award-winning FDA compliance expert, to give step-by-step advice on how to put the best foot forward prior to an inspection and understand the actions to take during and after the closeout meeting. Falls Church, VA (PRWEB) October 22, 2014 Preparing for an FDA Inspection:...

2014-10-21 23:13:16

Lawrence Livermore National Laboratory researchers recently published an article in PLOS ONE detailing the use of supercomputers to link proteins to drug side effects. The research showed their computational model of predicting side effects to be more predictive than current statistical methods in two cases, and the calculations also predicted new potential side effects. Livermore, California (PRWEB) October 21, 2014 New medications created by pharmaceutical companies have helped millions...

2014-10-17 23:07:09

On October 10, the FDA announced that certain unexpired human and veterinary sterile products by Oregon Compounding Centers, Inc. are recalled due to lack of sterility assurance. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) October 17, 2014 AttorneyOne.com, a recognized authority on law, updates the website daily regarding all the latest information from the FDA on sterile...

2014-10-15 12:32:31

LONDON, Oct. 15. 30, 2014 /PRNewswire/ -- REPORT HIGHLIGHTS The global market for ADC drugs reached $179 million in 2012 and $396 million in 2013. The market should reach $2.8 billion in 2018 with a compound annual growth rate (CAGR) of 48.1%. This report provides:An overview of the global market for ADCs as a part of the pharmaceutical industry that is looking for innovative technologies.Analyses of global market trends, with data from 2012, 2013, and projections of compound annual...

2014-10-13 23:08:53

U.S. Food and Drug Administration selects DRT Strategies as the sole prime contractor for its five-year, Blanket Purchase Agreement to provide CDRH Information Management Support services. Arlington, Virgina (PRWEB) October 13, 2014 DRT Strategies, Inc. (DRT) (http://www.drtstrategies.com), a leading management and technology consulting firm to federal agencies, the U. S. Navy, and commercial technology and financial services clients, announced today that the U.S. Food and Drug...

2014-10-13 16:25:01

WEST HOLLYWOOD, Calif., Oct. 13, 2014 /PRNewswire-USNewswire/ -- Records show that Dr. Kuemmerle, a methamphetamine addict, was the most prolific prescriber of Adderall and the second-highest prescriber of narcotics in the state. His reckless prescribing went uninvestigated until a drug dealer Dr. Kuemmerle was selling prescriptions to was arrested by an undercover officer. The police investigation found that Dr. Kuemmerle was writing prescriptions to people he had never met, with...


Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related